PolyPeptide Group AG (“PolyPeptide”) has been informed that Draupnir Holding B.V. (“Draupnir”), which held 60.0% of PolyPeptide’s share capital as of close of trading on SIX Swiss Exchange yesterday, placed a total of 1,500,000 existing ordinary shares in PolyPeptide (representing approx. 4.5% of PolyPeptide’s share capital) through an accelerated bookbuilding offering to institutional investors overnight. Upon settlement of the placement, which is expected to occur on 12 November 2021 subject to customary closing conditions, Draupnir will hold approx. 55.5% of PolyPeptide’s share capital. The free float in PolyPeptide shares, which according to SIX Swiss Exchange is presently 40.0%, will increase by approx. 4.5% to approx. 44.5%.
In the context of the placement, Draupnir has undertaken a lock-up commitment for a period of 130 days with respect to shares in PolyPeptide that will remain in its possession upon completion of the placement and PolyPeptide has been informed that Draupnir is committed to maintain a majority ownership in PolyPeptide for the foreseeable future.
PolyPeptide Group AG
Head of Investor Relations & Corporate Communications
Tel. +41 41 723 20 34
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) focusing on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products. Dating back to 1952, PolyPeptide today manufactures around one-half of all currently approved peptide drug substances with a global footprint of six GMP-certified facilities in Europe, the U.S. and India. As a multinational company with more than 1,000 employees, its diversity brings breadth, depth of knowledge and experience to the Group. PolyPeptide has grown organically and by selective acquisition of existing expertise, culminating in its position today as a leader in outsourced peptide manufacturing. PolyPeptide’s shares (SIX: PPGN) are listed on SIX Swiss Exchange. For more information, visit polypeptide.com.
PolyPeptide Group AG, Dammstrasse 19, CH-6300 Zug
This announcement is not an offer of securities into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), and may not be offered, pledged, sold, delivered or otherwise transferred, directly or indirectly, in the United States, except pursuant to an exemption from, or transaction not subject to, the registration requirements of the Securities Act. No public offering of securities is being made in the United States. Further, the securities referred to herein have not been and will not be registered under the applicable securities laws of Canada, Australia or Japan or under the applicable securities laws of any other jurisdiction where to do so might constitute a violation of such laws.
This document contains forward-looking statements including, but not limited to, statements regarding the completion of the transaction described herein, and Draupnir’s investment in PolyPeptide Group AG. These forward-looking statements are subject to change based on known or unknown risks and various other factors that could cause actual results, performance or events to differ materially from the statements made herein.
File: Release Draupnir ABB_E
End of ad hoc announcement
The necessary cookies help to make a website usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.
Marketing cookies are used to track visitors through websites. The goal is to display ads that are relevant and interesting to the individual user and therefore more valuable to third-party publishers and advertisers.
Statistical cookies help website owners, through the anonymous collection and communication of information, to understand how visitors interact with websites.
Preferences cookies allow a website to retain information that changes the way the site behaves or displays, such as your preferred language or the region in which you are located.